Sinovac Biotech Ltd (SVA)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Wei D. Yin
Employees:
4,280
39 SHANGDI XI ROAD, HAIDIAN DISTRICT, BEIJING, CHINA 100085
86-10-82890088

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, and trade of pharmaceutical products. It operates through the Mainland China and Hong Kong geographical segments. It develops and markets human vaccines under the following brands: Inlive, Healive, Bilive, Anflu, PANFLU.1, and Panflu. The company was founded in 1993 and is headquartered in Beijing, China.

Data derived from most recent annual or quarterly report
Market Cap 639.904 Million Shares Outstanding98.903 Million Avg 30-day Volume 8.297 Thousand
P/E Ratio5.9673 Dividend Yield0.0 EPS1.08
Price to Revenue0.4313 Debt to Equity0.0009 EBITDA-7.719 Million
Price to Book Value0.0722 Operating Margin-31.221799999999998 Enterprise Value-7.536 Billion
Current Ratio11.109 EPS Growth-0.987 Quick Ratio10.855
1 Yr BETA 0.3431 52-week High/Low 0.0 / Profit Margin5.9039
Operating Cash Flow Growth-105.0203 Free Cash Flow to Firm (FCFF) TTM -2.68 Billion Free Cash Flow to Equity (FCFE) TTM-2.016 Billion
Altman Z-Score1.9978
View SEC Filings from SVA instead.

Funds Holding SVA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SVA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SINOVAC BIOTECH LTD SVA 2021-10-15 22:15:04 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 21:45:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 21:15:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 20:45:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 20:15:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 19:45:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 19:15:04 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 18:45:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 18:15:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 17:45:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 17:15:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 16:45:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 16:15:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 15:45:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 15:15:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 14:45:02 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 14:15:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 13:45:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 13:15:03 UTC -2.2271 2.2971 7000
SINOVAC BIOTECH LTD SVA 2021-10-15 12:45:03 UTC -2.2271 2.2971 7000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
SARATOGA ADVANTAGE TRUST- James Alpha Multi Strategy Alternative Income Portfolio SVA -1597.0 shares, $-10332.59 2021-02-28 N-PORT
James Alpha Funds Trust- Easterly Multi Strategy Alternative Income Fund SVA -1597.0 shares, $-10332.59 2022-05-31 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments